What is CellX?
CellX is at the forefront of developing sustainable animal protein for the Chinese market. By leveraging advanced cell culture processes and cutting-edge tissue engineering techniques, the company aims to bypass traditional animal agriculture, offering a more environmentally conscious alternative. Founded in 2020, CellX's commitment to innovation positions it as a key player in the burgeoning alternative protein sector, addressing both consumer demand and environmental concerns.
How much funding has CellX raised?
CellX has raised a total of $14.8M across 2 funding rounds:
Unspecified
$4.2M
Series A
$10.6M
Unspecified (2021): $4.2M, investors not publicly disclosed
Series A (2022): $10.6M led by Joyvio Capital
Key Investors in CellX
Joyvio Capital
Joyvio Capital is an investor that has participated in CellX's funding rounds. Their involvement suggests a strategic interest in the food technology and biotechnology sectors.
What's next for CellX?
With substantial backing, CellX is poised for significant expansion and further development of its proprietary cell culture technologies. The recent major strategic investment suggests a focus on scaling production capabilities and potentially broadening its market reach within China and beyond. Future endeavors will likely involve navigating regulatory landscapes, optimizing manufacturing processes, and solidifying its position as a leader in the cultivated meat industry, driving the future of sustainable food production.
See full CellX company page
